学術論文　2021

  1. Tanaka, K.; Maekawa, S.; Yoshida, T.; Yamaguchi, T.; Takano, S.; Matsuda, S.; Hayakawa, H.; Ishida, Y.; Muraoka, M.; Kawakami, S.; et al. Role of magnifying endoscopy with narrow-band imaging in the diagnosis of noninvasive gastric neoplasia. JGH Open 2021, 5, 446–453, doi:10.1002/jgh3.12513.
  2. Tanaka, T.; Okuyama-Dobashi, K.; Motohashi, R.; Yokoe, H.; Takahashi, K.; Wiriyasermkul, P.; Kasai, H.; Yamashita, A.; Maekawa, S.; Enomoto, N.; et al. Inhibitory effect of a novel thiazolidinedione derivative on hepatitis B virus entry. Antiviral Res. 2021, 194, 105165, doi:10.1016/j.antiviral.2021.105165.
  3. Higuchi, M.; Tamaki, N.; Kurosaki, M.; Inada, K.; Kirino, S.; Yamashita, K.; Hayakawa, Y.; Sekiguchi, S.; Osawa, L.; Takaura, K.; et al. Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C. J. Med. Virol. 2021, 93, 3744–3751, doi:10.1002/jmv.26490.
  4. Itakura, J.; Kurosaki, M.; Setoyama, H.; Simakami, T.; Oza, N.; Korenaga, M.; Tanaka, M.; Torimura, T.; Sakamoto, N.; Enomoto, N.; et al. Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis. J. Gastroenterol. 2021, 56, 470–478, doi:10.1007/s00535-021-01782-3.
  5. Ma, Y.-H.; Yamaguchi, T.; Yasumura, T.; Kuno, T.; Kobayashi, S.; Yoshida, T.; Ishida, T.; Ishida, Y.; Takaoka, S.; Fan, J.-L.; et al. Pancreatic cancer secondary to intraductal papillary mucinous neoplasm with collision between gastric cancer and B-cell lymphoma: A case report. World J. Clin. cases 2021, 9, 2400–2408.
  6. Takano, S.; Fukasawa, M.; Shindo, H.; Takahashi, E.; Fukasawa, Y.; Kawakami, S.; Hayakawa, H.; Kuratomi, N.; Kadokura, M.; Maekawa, S.; et al. Digital next-generation sequencing of cell-free DNA for pancreatic cancer. JGH open an open access J. Gastroenterol. Hepatol. 2021, 5, 508–516, doi:10.1002/jgh3.12530.
  7. Kuratomi, N.; Takano, S.; Fukasawa, M.; Maekawa, S.; Kadokura, M.; Shindo, H.; Takahashi, E.; Hirose, S.; Fukasawa, Y.; Kawakami, S.; et al. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing. Int. J. Mol. Sci. 2021, 22, doi:10.3390/ijms22063221.
  8. Takano, S.; Fukasawa, M.; Shindo, H.; Takahashi, E.; Hirose, S.; Fukasawa, Y.; Kawakami, S.; Hayakawa, H.; Kuratomi, N.; Kadokura, M.; et al. Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens. Cancer Med. 2021, 10, 1264–1274, doi:10.1002/cam4.3723.
  9. Tahata, Y.; Hikita, H.; Mochida, S.; Kawada, N.; Enomoto, N.; Ido, A.; Yoshiji, H.; Miki, D.; Hiasa, Y.; Takikawa, Y.; et al. Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study. J. Gastroenterol. 2021, 56, 67–77, doi:10.1007/s00535-020-01733-4.
  10. Matsuda, S.; Maekawa, S.; Komiyama, Y.; Nakakuki, N.; Muraoka, M.; Suzuki, Y.; Sato, M.; Tatsumi, A.; Miura, M.; Amemiya, F.; et al. Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy. Hepatol. Res. 2021, 51, 39–50, doi:10.1111/hepr.13574.
  11. Takada H, Osawa L, Komiyama Y, Kato R, Nakakuki N, Muraoka M, et al. Usefulness of Circulating CYFRA21-1 in Patients as a Biomarker in Patients Taking Sorafenib or Lenvatinib for Unresectable Hepatocellular Carcinoma. Reports 2021, Vol 4, Page 25 
  12. Muraoka, M.; Maekawa, S.; Katoh, R.; Komiyama, Y.; Nakakuki, N.; Takada, H.; Matsuda, S.; Suzuki, Y.; Sato, M.; Tatsumi, A.; et al. Usefulness of Cell-Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy. Hepatol. Commun. 2021, 0, hep4.1762, doi:10.1002/HEP4.1762.